Apr 28, 2023 | Commentary, Value-Based Drug Management
Obesity is clearly a national problem that impacts employee health and productivity, as well as health plan costs. Enter the wave of pricey new GLP-1 weight-loss and diabetes medications ꟷ a cost driver for plan sponsors and potential panacea for members. (more…)
Apr 14, 2023 | Legislative Updates
The deadline for health plans and health insurance issuers to submit their second prescription drug data collection (RxDC) report is June 1, 2023. This is an annual reporting requirement; plans and issuers will generally submit these reports by June 1 of each year, reporting information for the prior calendar year. Read more…
